Maciag, A. E., Chakrapani, H., Saavedra, J. E., Morris, N. L., Holland, R. J., Kosak, K. M., . . . Keefer, L. K. (2011). The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The American Society for Pharmacology and Experimental Therapeutics.

Maciag, Anna E., Harinath Chakrapani, Joseph E. Saavedra, Nicole L. Morris, Ryan J. Holland, Ken M. Kosak, Paul J. Shami, Lucy M. Anderson, and Larry K. Keefer. The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The American Society for Pharmacology and Experimental Therapeutics, 2011.

Maciag, Anna E., et al. The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The American Society for Pharmacology and Experimental Therapeutics, 2011.